U.S. stock movement quick report: Moolec Science surged 37.58%, Rambus plummeted 15.08%, attracting market attention

In the past hour, the overall market in the U.S. stock market has shown a clear divergence, with technology and pharmaceutical stocks performing particularly well. The strong rise of Moolec Science SA has attracted market attention, with an increase of 37.58%, indicating enthusiasm from short-term funds. On the other hand, individual stocks such as Rambus and Vivakor have experienced significant declines, dropping 15.08% and 13.10% respectively, reflecting fluctuations in market sentiment and caution among investors. Overall, it seems that short-term enthusiasm is switching between small-cap stocks and thematic stocks, with considerable volatility and complex investor sentiment. The notable increase of 37.58% in Moolec Science SA, the most active stock in the past hour, appears to be driven by market expectations for its new products, leading to a rapid influx of short-term funds and a warming of overall sentiment. In contrast, the decline of Rambus stands out sharply, with a drop of 15.08% reflecting market concerns about its future prospects and a clear outflow of funds. Strong stocks include: 1. KALA BIO: up 11.64%, driven by optimistic expectations for its new drug development. 2. Sumitomo Mitsui Financial: up 4.67%, performing well in the financial sector with stable fund inflows. 3. Mitsubishi UFJ Financial: up 4.07%, benefiting from the market's reassessment of financial stocks, with active short-term fund involvement